Clinical Trials Directory

Trials / Unknown

UnknownNCT04360408

The Energy Conservation Education Intervention

The Energy Conservation Education Intervention For People With End-stage Kidney Disease Receiving Haemodialysis (EVEREST)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
126 (estimated)
Sponsor
Queensland University of Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Fatigue is the most common symptom reported by 70 - 85 % of people with end-stage kidney disease (ESKD) receiving haemodialysis (HD). Educational interventions involving energy conservation strategies are helpful in reducing fatigue. However, the effectiveness of energy conservation has not been previously studied in people with ESKD receiving HD. This study aims to develop and evaluate the effectiveness of energy conservation education intervention for people with end-stage kidney disease receiving haemodialysis (EVEREST) in Nepal. Symptom Management Theory (SMT) will guide this study. A pragmatic cluster randomised controlled trial (pCRT) will be conducted in one dialysis centre in Nepal. People on HD who meet the eligibility criteria will be invited to participate. The primary outcome is fatigue severity and the secondary outcome are other renal symptoms, occupational performance and health-related quality of life. Intention to treat analysis will occur and will include a change in the primary and secondary outcome. The study will provide evidence about the feasibility and effectiveness of EVEREST for symptom management.

Conditions

Interventions

TypeNameDescription
OTHEREnergy conservation education intervention for people with end-stage kidney disease receiving hemodialysisThe total program consisting of three educational sessions (at Week -1, week -3 and week -5) and one booster session (week -10) over a period of 12 weeks. Participants will receive individual, face to face education during their regular HD session. Education will be provided over 30-45 minutes for the first session, 30 minutes in the next two sessions and 30-45 minutes for the booster session. The lead researcher, who is a nurse, will deliver the entire intervention to avoid information bias. The simple language will be used, and emphasis will be given on the objectives of each session.

Timeline

Start date
2020-08-01
Primary completion
2021-06-01
Completion
2023-02-01
First posted
2020-04-24
Last updated
2020-04-24

Source: ClinicalTrials.gov record NCT04360408. Inclusion in this directory is not an endorsement.